Home › Funds › Eagle Health Investments LP › ALKS
Eagle Health Investments LP position in ALKS
ALKERMES PLC · Health Care
Eagle Health Investments LP reported holding 297,302 shares of ALKS (ALKERMES PLC) in its Q3 2026 13F filing — a position valued at US$12.0M, representing 2.17% of its reported portfolio and ranking #16 among its reported holdings. Eagle Health Investments LP has disclosed ALKS holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Eagle Health Investments LP's ALKS position evolved
Eagle Health Investments LP first disclosed a stake in ALKS in Q3 2025 at 81,800 shares (US$2.5M). The position peaked in Q2 2026 at 297,302 shares, worth US$15.6M. Across 5 filings, Eagle Health Investments LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 297,302 shares valued at US$12.0M. Notable position changes include a 192% increase in Q1 2026 (shares rose 48% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 81.80K | $2.45M | New |
| Q4 2025 | 81.80K | $2.29M | Hold |
| Q1 2026 | 238.67K | $8.44M | Add |
| Q2 2026 | 297.30K | $15.58M | Add |
| Q3 2026 | 297.30K | $12.05M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALKS and 13F data
ALKS (ALKERMES PLC) is a Health Care company. 38 other funds we track also report a position in ALKS — the largest reported positions include BAKER BROS. ADVISORS LP (US$524.6M), Renaissance Technologies (US$263.1M), Deep Track Capital, LP (US$209.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALKS
- BAKER BROS. ADVISORS LP 10.01M sh · $524.59M · Q2 2026
- Renaissance Technologies 6.49M sh · $263.13M · Q3 2026
- Deep Track Capital, LP 4.00M sh · $209.58M · Q2 2026
- Commodore Capital LP 3.00M sh · $157.19M · Q2 2026
- BVF INC/IL 2.15M sh · $112.90M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 1.94M sh · $101.54M · Q2 2026
- RTW INVESTMENTS, LP 1.67M sh · $87.62M · Q2 2026
- Soleus Capital Management, L.P. 1.03M sh · $53.93M · Q2 2026
More on Eagle Health Investments LP
FAQ
How long has Eagle Health Investments LP held ALKS?
Eagle Health Investments LP has disclosed ALKS holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Eagle Health Investments LP's current position in ALKS?
As of Q3 2026, Eagle Health Investments LP holds 297.30K shares of ALKS (ALKERMES PLC), valued at $12.05M, representing 2.17% of its reported portfolio and ranking #16.
Has Eagle Health Investments LP been buying or selling ALKS?
In the latest 13F filing (Q3 2026), Eagle Health Investments LP held unchanged its position in ALKS. The position peaked in Q2 2026 at 297.30K shares.
Which other funds hold ALKS?
Other major institutional holders of ALKS include BAKER BROS. ADVISORS LP, Renaissance Technologies, Deep Track Capital, LP, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.